Aragues Alain 4

Accession 0001416038-11-000002

CIK 0000873364other

View on SEC.gov Company Profile

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 11:57 AM ET

Size

27.5 KB

Accession

0001416038-11-000002

Insider Transaction Report

Form 4

Period: 2011-10-14

CEPHALON INCCEPH

Aragues Alain

Exec. V.P.,President of Europe

Transactions

Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−25,000→ 0 total
Exercise: $64.62From: 2006-02-01Exp: 2012-02-01→ Common Stock (25,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−300→ 0 total
Exercise: $48.06From: 2008-12-16Exp: 2014-12-16→ Common Stock (300 underlying)
Disposition to Issuer
Incentive Stock Option
2011-10-14−6,336→ 0 total
Exercise: $63.11From: 2014-12-16Exp: 2020-12-16→ Common Stock (6,336 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−4,300→ 0 total
Exercise: $71.07From: 2010-12-19Exp: 2016-12-19→ Common Stock (4,300 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−43,664→ 0 total
Exercise: $63.11From: 2014-12-16Exp: 2020-12-16→ Common Stock (43,664 underlying)
Disposition to Issuer
Common Stock
2011-10-14−42,275→ 0 total
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−5,200→ 0 total
Exercise: $76.11From: 2011-12-13Exp: 2017-12-13→ Common Stock (5,200 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−5,200→ 0 total
Exercise: $73.25From: 2012-12-11Exp: 2018-12-11→ Common Stock (5,200 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−4,300→ 0 total
Exercise: $51.08From: 2009-12-01Exp: 2015-12-01→ Common Stock (4,300 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−15,000→ 0 total
Exercise: $59.03From: 2013-07-30Exp: 2019-07-30→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−15,000→ 0 total
Exercise: $56.07From: 2013-12-02Exp: 2019-12-02→ Common Stock (15,000 underlying)

Footnotes (4)

[F1]Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
[F2]Includes 19,950 shares of Restricted Stock with certain vesting restrictions, which restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger.
[F3]Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
[F4]Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CEPHALON INC

CIK 0000873364

→

Entity typeother

Related Parties

filerCIK 0001483588

Filing Metadata

Form type: 4
Filed: Oct 16, 8:00 PM ET
Accepted: Oct 17, 11:57 AM ET
Size: 27.5 KB

View on SEC.gov